Your browser doesn't support javascript.
loading
Omalizumab for treatment of idiopathic angioedema.
Goswamy, Vinay P; Lee, Kristine E; McKernan, Elizabeth M; Fichtinger, Paul S; Mathur, Sameer K; Viswanathan, Ravi K.
Afiliación
  • Goswamy VP; Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. Electronic address: vgoswamy@wisc.edu.
  • Lee KE; Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • McKernan EM; Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Fichtinger PS; Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Mathur SK; Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Viswanathan RK; Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Ann Allergy Asthma Immunol ; 129(5): 605-611.e1, 2022 11.
Article en En | MEDLINE | ID: mdl-35914662

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Urticaria / Antialérgicos / Urticaria Crónica / Angioedema Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Urticaria / Antialérgicos / Urticaria Crónica / Angioedema Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article